Mediators of the Effects of Canagliflozin (CANA) on Heart Failure (HF) and CV Death in Patients with Type 2 Diabetes (T2D) and Chronic Kidney Disease (CKD)

Jingwei Li, Bruce Neal, Hiddo L. Heerspink, Clare Arnott, Christopher Cannon, Rajiv Agarwal, George Bakris, David M. Charytan, Dick de Zeeuw, Tom Greene, Adeera Levin, Richard Oh, Carol A. Pollock, David C. Wheeler, Yshai Yavin, Hong Zhang, Bernard Zinman, Gian Luca Di Tanna, Vlado Perkovic, Kenneth W. MahaffeyMeg Jardine

Onderzoeksoutput: Meeting AbstractAcademic

Originele taal-2English
Aantal pagina's3
TijdschriftDiabetes
Volume69
DOI's
StatusPublished - jun.-2020
Evenement80th Scientific Sessions of the American-Diabetes-Association (ADA) -
Duur: 12-jun.-202016-jun.-2020

Citeer dit